Tourmaline Bio - 53 Year Dividend History | TRML
Historical dividend payout and yield for Tourmaline Bio (TRML) since 1971. The current TTM dividend payout for Tourmaline Bio (TRML) as of November 21, 2024 is $0.00. The current dividend yield for Tourmaline Bio as of November 21, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.590B |
$0.000B |
|
Tourmaline Bio Inc. is a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune diseases. The company's lead program includes TOUR006. Tourmaline Bio Inc., formerly known as Talaris Therapeutics Inc., is based in NEW YORK.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
